#ebr: development

[sgtyaraya]

Call of Duty OC

Name: Trudy Saidler

Nikename: Jay

Date of birth: June 01, 1992

Age: 24 (at the time of the events in 2016)

Place of birth: Liberec, Czech Republic🇨🇿

Citizenship: Czech🇨🇿

Nationality: English 🇬🇧

Rank: Sergeant

Specialty: Infantryman

Unit: TF - 141

Family/Relationships

Mother: Adele Saidler (Hofmann) 🇬🇧

Father: Philip Saidler 🇬🇧

Brother: Evan Saidler🇬🇧 ✝️

Love Interest: Gary "Roach" Sanderson🇬🇧💕

Reference/appearance

Trudy on the day she arrived at Credenhill

Parameters

Hair: brown with light strands

Eyes: grey

Pigmentation on the body: freckles

Tattoo: on the left arm

Scars: scratches on the right and left arm, a bullet wound in the left shoulder, suture marks on the right side at the rib level, bullet wounds in the abdomen, cartilage injury of the right ear

Height: 170 cm

Weight: 60 kg

Body type: normal

Equipment

Armored vest: warrior "plates" assault systems

M4A1 assault rifle with a grenade launcher

M14 EBR sniper rifle with silencer for long-range elimination and, if necessary, to cover the group

Pistols: M9 and USP.45

Cold steel: Alpha S D2 knife Tactical Knife and Custom Steel Machete D2 Machete Etsy Knife

Personality

Trudy is a young girl with sociability and good nature. Her attitude towards people depends on how they treat her: if they show a positive attitude towards her, she is a little stubborn. Even so, Trudy is not so trusting, so she does not immediately open up to the interlocutor. Trudy sometimes experiences moments that can cause irritation. And in such cases, she can flare up, allowing her emotions to come out. However, she tries to control her emotions so as not to show them to other people. But Trudy's weakest side is her worries. Everything that she experiences inside herself, she tries to hide from others.

Fears

🔥Pyrophobia🔥is a phobia consisting in a constant, irrational, obsessive, panic fear of fire, fires; an obsessive fear of burning alive, getting burned, or losing property as a result of a fire. (in one of the missions, she almost burned herself in the room in which she was locked, losing consciousness)

Biography

Trudy's parents live in the Czech Republic for most of their lives, they have successfully established their lives in another country, and we can say they have lived in it for most of their lives, and did not want to return to England. Adele Saidler (Hofmann) has opened her own atelier in Liberec, where they now live. The woman is engaged in custom tailoring, previously she was specialized in sewing military uniforms. Philip Saidler is a former infantryman, retired for health reasons, retired, but he helps his wife in the atelier, delivering sewing materials. He also earns a living on the outskirts of the city, but there is no information about his place of work. Before Trudy, they had a son, Evan Saidler [date of birth unknown, died as a teenager, cause of death unknown]. The couple suffered a hard loss, and were very worried about their daughter, who knows about her late brother.

Trudy's childhood, like that of ordinary children, was no different from them. She also had her own hobbies, which her parents reacted positively to, and supported their daughter in every possible way, most importantly. The girl was actively engaged in dancing from the age of 12, from which she developed flexibility, there were even performances on behalf of the school. She also loved to help her mother in the atelier, more often looked after the counter, and thus engaged in needlework, she could also sew some clothes with jewelry. In addition to dancing, Trudy also had hobbies, which she does not mention.

During her student years, Trudy met a girl who was 1 year younger than her, Linda Kovac (Czech). She was always an inconspicuous gray mouse, but Trudy became friends with her on the first day they met, and spent more and more time together. Thanks to her, Linda began to gain self-confidence and even changed her style in order not to fall into the gray mass and stand out somehow. Saidler never sought to attract attention, preferring to wear comfortable and not too bright clothes, and studied like all ordinary students. She needed Czech to learn, so even at preschool age she learned this language, English is considered the main one.

There have been mistakes in Trudy's life, one of them has undermined people's trust. As a student, a guy was in love with her, and he sought her attention in every possible way. The student's infatuation, yes, did not last long. This guy dated her for a joke, enjoyed her trust. After receiving her education, Trudy left Liberec and went to England. After living there for some time, she went to Credenhill, where the selection for group 141 was held. During the trip, Trudy heard other recruits talking about this group, and who is in it, quite big names sounded from the mouths of the guys, which made her interested. Arriving at their base, Trudy did not expect to see the members of the 141 group live. At the time, Captain McTavish was in charge of the selection, and he took up her training in order to make Saidler an experienced fighter. As a rookie, she was sent for additional training to improve her skills and adapt to work in group 141. During her stay at the base, Trudy met Roach, a young sergeant whom she saw on the day of her arrival. At first, things didn't go very well due to distrust, so we gradually communicated. Jay showed a special interest in Roach as a person and wanted to get to know him better, and thus she awakened trust in him. Roach also showed interest in the girl and communicated with her even from a distance. Trudy was very afraid of attachment to people, and hid her sympathy until the last moment, Roach had the same feelings for her. They gradually showed warm feelings for each other.

Participation

Jay began his service under the command of Captain McTavish, took his first part in the Hunting mission, where the goal was to catch Alejandro Rojas, worked in a group with Roach. In the future, she participated in assaults at certain points, provided cover, engaged in inconspicuous liquidation

The history of the creation of the OC

In 2011, I played with COD Modern warfare 2 for the first time. This game has left vivid moments in my memory, from joyful to sad, my favorite mission is "Rock Climber". At that moment, the first character appeared in my head. Since I couldn't draw at the age of 9, I was building a plot in my head. There is an important point, this is the date when I started playing and when I came up with Trudy. This is June 1, 2011, and this date is also Trudy's date of birth.

In her first version, there was no first or last name, I just called her "Emersan", this call sign is taken from another game that I also actively played. As for her appearance, Trudy looked different, not like she does now. In 2018, I visually sketched her portrait, hoping for my memory. Based on this, I decided to change her appearance, and also attached my old works. As time went on, I always wanted to add something, it seemed to me that Trudy was too simple. Although yes, she really was like that. Then, during the redrawing, I already gave her a name. Her name was Trudy "Emersan" Sombra. She later became Jay, the new surname is Saidler. Trudy's redesigns didn't last long, so I changed it again by drawing new references. You can see that she has hardly changed since 2019, there are small changes on her face – freckles and hair color have become darker. Next comes the tattoo. It was a difficult choice, I came up with the first tattoo myself, then I made another, more complex one. The final version was drawn in 2023, and received a reference

Trudy in 2011 to 2022

[kennak]

この本で最も重要なページを挙げよと言われたらこの図を挙げる。 SR = Sales Representative マーケティングから渡されるリード（見込み顧客の連絡先のこと）にコンタクトして脈がありそうなら商談として営業（フィールドセールス）に渡す役割。うちの会社では SDR = Sales Development Representative という肩書きで呼ばれてる。 EBR = Enterprise Business Representative インサイドセールスの一種だがリードが渡されるのを待たずにターゲット企業に自らコンタクトをとって商談を作り営業に渡す役割。主に大企業の役職者などに絞って営業をかける。オンライン飛び込み営業。 AE = Account Executive いわゆる営業（フィールドセールス）。顧客を訪問して商談をまとめる。大手企業担当と SMB = Small Medium Business 中小企業担当で分かれる。 CSM = Customer Success Manager 受注後の顧客をフォローして、製品の利活用を促進し、サブスクリプション型サー���スの継続利用を目指す。 インサイドセールスで経験を積み、フィールドセールスにキャリアアップしていくというキャリアパスにもなっているらしい。SR (SDR) が相対するのはリードで、そもそも自社製品に関心がある相手。なので経験が浅くても務まりやすい。EBR になると関心を持ってない相手に関心を持たせるスキルがいる。SMB の AE になると商談をまとめて受注するクロージングのスキルを磨き、やがては大企業の AE として大きな商談をまとめていく。

THE MODEL（MarkeZine BOOKS） マーケティング・インサイドセールス・営業・カスタマーサクセスの共業プロセス - @kyanny's blog

[simranmakhija1]

Empowering Hearts: Transforming Care with Leadless Pacemakers

The leadless pacemakers market has emerged as a revolutionary segment within cardiac rhythm management, offering a promising alternative to traditional pacemaker systems. With a focus on eliminating the need for leads and simplifying implantation procedures, leadless pacemakers have captured the attention of healthcare providers, patients, and industry stakeholders alike.

Get a free Sample: https://www.marketdigits.com/request/sample/3891 

Major vendors in the global Leadless pacemakers market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, Lepu Medical Technology Co., Ltd, Integer Holdings Corporation, MicroPort Scientific Corporation, Osypka AG, Terumo Corporation, and EBR Systems, Inc. and Others

One of the primary drivers behind the growth of the leadless pacemakers market is the focus on patient safety and comfort. Traditional pacemakers require the placement of leads within the heart, which can pose risks such as infection, lead dislodgement, and vein damage. In contrast, leadless pacemakers deliver pacing therapy directly from within the heart, reducing the potential for complications associated with lead placement and improving patient outcomes.

In 2024, the Leadless Pacemakers Market is valued at USD 600.31 million and is projected to reach USD 1,676.23 million by 2030, showcasing a growth rate of 15.8% CAGR during the forecast period from 2024 to 2032.

Moreover, the focus on innovation and technological advancements has propelled the leadless pacemakers market forward. Companies are investing in research and development to enhance device performance, durability, and battery life while minimizing device size and improving ease of implantation. These efforts have resulted in the introduction of next-generation leadless pacemakers with advanced features such as longer battery longevity, enhanced sensing capabilities, and compatibility with magnetic resonance imaging (MRI).

The focus on expanding adoption rates and addressing key challenges is also driving growth in the leadless pacemakers market. Physicians are increasingly recognizing the benefits of leadless pacemakers in select patient populations, including those with limited venous access or a high risk of infection. Additionally, patients are becoming more informed and proactive in their healthcare decisions, seeking out innovative treatment options that offer improved safety, efficacy, and quality of life.

However, to fully realize the potential of leadless pacemakers, addressing key concerns such as long-term efficacy, reimbursement policies, and economic viability is crucial. While early clinical studies have shown promising outcomes, larger real-world studies and long-term follow-up are needed to validate these findings and address concerns regarding device performance and reliability over time. Additionally, reimbursement policies and healthcare economics play a significant role in shaping market dynamics and adoption rates, highlighting the importance of demonstrating the cost-effectiveness of leadless pacemakers compared to traditional pacemakers.

In conclusion, the leadless pacemakers market is characterized by a focus on innovation, patient safety, and expanding adoption rates. With ongoing advancements in technology and a growing emphasis on addressing key challenges, the leadless pacemakers market is poised for continued growth and impact on patient care.

[processxe]

Unlocking Efficiency and Compliance with Electronic Batch Records

The requirement for simplified procedures and strong regulatory compliance has never been more crucial in the ever-changing environment of the manufacturing and pharmaceutical sectors. Electronic Batch Records (EBRs) arise as a game changer, revolutionizing how enterprises manage and document their manufacturing operations. In this blog, learning about what they are, how they work, and how they're changing the future of manufacturing. Development of Batch Records

Batch records were traditionally paper-based documentation that documented the phases of a manufacturing process. These records were not only difficult to handle, but they were also disposed to to mistakes, inefficiencies, and compliance problems. It was a difficult undertaking to keep these records up to date, retrieve past data, and ensure compliance with changing regulations. Electronic Batch Records: A Switchover

Introduction of Electronic Batch Records signaled a revolution in how industry managed their production operations. EBRs replace stacks of paper with digital records, which has various advantages.

EBRs remove the risk of human mistakes associated with manual data entry, resulting in increased accuracy and efficiency. Data gathering and validation methods that are automated ensure that information is correct and up to date. This results in fewer manufacturing mistakes, less waste, and more efficiency.

With EBRs, you can monitor manufacturing processes in real time. This not only allows for speedier decision-making but also gives significant insights into the manufacturing workflow. Managers can quickly identify bottlenecks and inefficiencies and implement remedial actions.

Compliance with industrial rules is of the utmost importance. EBRs make compliance easier by automatically recording each stage of the manufacturing process, ensuring that all necessary data is gathered and securely preserved. This makes audits and regulatory inspections easier.

EBRs make it simple to retrieve past data. This is extremely useful for tracking product quality, investigating issues, and continuously improving. It also makes it easier to generate batch-related reports.

Collaboration across teams in various places is frequent in today's globalized environment. EBRs provide remote access and collaboration, allowing teams to collaborate effortlessly regardless of their geographical location.

Implementing Electronic Batch Records

EBR implementation necessitates careful planning and technological investment. The following are important goals in the implementation process:

Choosing the Right Software: Select EBR software that meets the demands and regulatory standards of your sector. Scalability should be considered to support future expansion.

Training: Provide training to your workers to guarantee they can utilize the EBR system properly. This involves knowing how to enter data, monitor operations, and fix problems.

Transferring data from paper-based records is referred to as data migration.

Process XE is web based, flexible and user-friendly software solutions for Business process automation.

For more details on MES, Contact our sales team. <Book A Demo>

[stevecarell600]

Medical Drone Market Share, Outlook & Global Opportunity Analysis by 2028

The global medical drone industry is projected to experience significant growth, reaching USD 1,410.9 million by 2028, up from USD 254.7 million in 2021, with an impressive CAGR of 27.70% during the period from 2021 to 2028. According to the "Medical Drone Market, 2021-2028" report by Fortune Business Insights™, the market had a valuation of USD 194.7 million in 2020. This remarkable growth can be attributed to the continuous technological advancements in the medical drone industry and the fierce competition among major players striving to deliver top-quality products.

Information Source:

Top Companies Covered in Medical Drone Industry are:

Zipline Inc. (San Francisco, The U.S.)

Volocopter GmbH (Bruchsal, Germany)

Volansi Inc. (San Francisco, United States)

Matternet Inc. (Mountain View, The U.S.)

Manna Drone Delivery Inc. (Dublin, Ireland)

Flytrex Aviation Ltd. (Tel Aviv, Israel)

Flirtey Holdings Inc. (Reno, The U.S.)

Vayu Inc. (Ypsilanti, The U.S.)

Skyports Ltd. (Billericay, The U.K)

Ebre Drone LLC (Tarragona, Spain)

Swoop Aero Pty. Ltd. (Docklands, Australia)

Skyfarer Ltd. (Coventry, The U.K)

The global medical drones were an emerging technology with significant potential in the healthcare industry. Medical drones, also known as healthcare drones or medical delivery drones, are unmanned aerial vehicles (UAVs) designed to transport medical supplies, equipment, and even organs between healthcare facilities or directly to patients in remote or inaccessible areas. These drones offer numerous benefits, including:

Faster delivery: Medical drones can significantly reduce transportation time for critical medical supplies, such as medicines, blood, vaccines, and diagnostic samples. They can bypass traffic congestion and access hard-to-reach locations, leading to faster responses in emergencies.

Remote access: In rural or isolated areas where road infrastructure is limited or inadequate, medical drones can provide essential medical supplies and support, bridging the healthcare access gap.

Disaster relief: During natural disasters or humanitarian crises, medical drones can deliver medical aid, food, and water to affected areas quickly, providing support to affected populations.

Cost-effective: Over time, medical drone services have the potential to be more cost-effective than traditional delivery methods, especially in regions where infrastructure development is expensive or challenging.

Reduced risk of infection: Medical drones can minimize human contact during delivery, potentially reducing the risk of spreading infectious diseases.

However, it is important to note that the widespread use of medical drones has been hindered by several challenges and considerations:

Regulatory hurdles: Integrating drones into the healthcare system requires navigating complex regulations and ensuring compliance with aviation authorities and healthcare agencies.

Safety concerns: Safety is a significant concern with any drone operation, especially when transporting medical supplies. Ensuring the reliability and redundancy of drone systems is crucial.

Weather limitations: Adverse weather conditions can affect the flight and safety of medical drones, making it necessary to establish weather-resistant and reliable drone models.

Payload capacity: Drones have limited payload capacities, and transporting bulky or heavy medical equipment might be challenging.

Since my knowledge is not up-to-date beyond September 2021, I recommend researching recent developments and news to get the latest information on the current state of medical drones and their applications in the healthcare industry.

[tastydregs]

Helion Energy Commits to Fusion Enegy Delivery to Microsoft in 2028

Helion Energy will provide Microsoft (MSFT.O) with electricity from nuclear fusion in about five years. It is the first purchase power agreement for commercial nuclear fusion energy.

Helion Energy (based in Washington State near Microsofts head office) agreed to provide Microsoft with at least 50 megawatts of electricity from its planned first fusion power plant, starting in 2028. Fifty megawatts is enough electricity to power a data center or factory, said David Kirtley, Helion’s CEO.

Founded in 2013, Helion has launched a multi-billion-dollar effort to produce electricity from fusion, the nuclear reaction that powers the sun and stars.

Helion Energy has received over $570 million in funding and commitments for another $1.7 billion to develop commercial nuclear fusion.

Helion has performed thousands of tests with their sixth prototype called Trenta. In 2021, Trenta reached 100 million degrees C, the temperature they could run a commercial reactor. Magnetic compression fields exceeded 10 T, ion temperatures surpassed 8 keV, and electron temperatures exceeded 1 keV. They reported ion densities up to 3 × 10^22 ions/m3 and confinement times of up to 0.5 ms.

7th prototype Polaris Helion’s seventh-generation prototype, Project Polaris was in development in 2021, with completion expected in 2024. The device was expected to increase the pulse rate from one pulse every 10 minutes to one pulse per second for short periods. This prototype is the first of its kind to be able to heat fusion plasma up to temperatures greater than 100 million degrees C. Polaris is 25% larger than Trenta to ensure that ions do not damage the vessel walls.

Helion’s plan with Polaris is to try demonstrate net electricity from fusion. They plan to demonstrate helium-3 production through deuterium-deuterium fusion.

The plan with Polaris is to pulse at a higher repetition rate during continuous operations.

8th prototype Antares As of January 2022, an eighth prototype, Antares, is in the design stage.

Helium-3 is an ultra-rare isotope of helium that is difficult to find on Earth used in quantum computing and critical medical imaging. Helion produces helium-3 by fusing deuterium in its plasma accelerator utilizing a patented high-efficiency closed-fuel cycle. Scientists have even discussed going to the Moon to mine helium-3 where it can be found in much higher abundance. Helion’s new process means we can produce helium-3 on Earth.

Helion’s cost of electricity production is projected to be $0.01 per kWh without assuming any economies of scale from mass production, carbon credits, or government incentives.

Nextbigfuture has interviewed Helion executives a few years ago and has reported on Helion plans before. Helion and all other nuclear fusion companies have missed target dates in the past. The only fusion companies that have not missed target dates are those that are too new.

All current nuclear fusion projects are less capable than the first EBR-1 fission reactor from 1951. However, technological and scientific breakthroughs can happen. Breakthroughs often do not happen. Nuclear fusion projects might succeed or might not. Many normal large projects fail. Multi-billion dollar skyscrapers and building projects that fail not because of difficult science. Big companies and big projects can fail and they can be late and miss deadlines. The SLS rocket is an example of a project going massively over budget and behind schedule.

December 2022 Update on Helion Energy Science

Helion Fusion CEO, David Kirtley, presented an update on the work as of December, 2022.

They are working on their seventh-generation prototype system and they have had over 10,000 shots with the sixth-generation system. They create and form plasmas and accelerate two plasmas to merge at supersonic speeds. They do not inject beams and operate in pulse mode. they do not hold the plasma for long times like the tokamak approaches.

The VC-funded seventh prototype should generate electricity. They have $500 million in funding and commitments of another $2 billion if the seventh prototype achieves its technical goals.

6th system is working at about 10 kEV (10 thousand electron volts). Over 10,000 shots. 7th system will work at 20 kEV. Want to have it operating by the end of 2023. 8th or 9th systems to get to the ideal operating levels of 100 kEV.

It is taking about 2-4 years to make and start operating each new prototype.

They have computational models of their science work and computationally modeled the scaling of the system.

Nextbigfuture has monitored all nuclear fusion programs and advanced nuclear fission systems. Helion Fusion is one of the programs that is the most promising based upon my comprehensive analysis.

The Operation of Helion Fusion Summarized

Scaling and Science Foundation

Brian Wang is a Futurist Thought Leader and a popular Science blogger with 1 million readers per month. His blog Nextbigfuture.com is ranked #1 Science News Blog. It covers many disruptive technology and trends including Space, Robotics, Artificial Intelligence, Medicine, Anti-aging Biotechnology, and Nanotechnology.

Known for identifying cutting edge technologies, he is currently a Co-Founder of a startup and fundraiser for high potential early-stage companies. He is the Head of Research for Allocations for deep technology investments and an Angel Investor at Space Angels.

A frequent speaker at corporations, he has been a TEDx speaker, a Singularity University speaker and guest at numerous interviews for radio and podcasts.  He is open to public speaking and advising engagements.

[lanshengic]

Semiconductor Lithography Materials Trending Upwards

TECHCET— the electronic materials advisory firm providing business and technology information on semiconductor supply chains — is forecasting the Semiconductor Lithography materials market to dip slightly, declining -2% in 2023, which follows the downward trends of the overall semiconductor market. This slowdown is expected to be short-lived, as 2024 forecasts indicate 9.4% growth over 2023, as highlighted in TECHCET’s most recent update to the Lithography Materials Critical Materials Report™. The Lithography materials segment, which includes photoresists and ancillaries (developers, ARCs, BARCs, EBRs, etc.), is estimated to grow 4.9% CAGR (2022-2027). The Ancillary materials segment alone is estimated to grow at a 5.1% CAGR over the same period.

The fastest growing lithographic materials continue to be EUV and thick KrF photoresists, both of which are driven by the introduction of new technologies: advanced Logic (EUV) and memory (DUV).  Metal oxide (MOX) negative tone EUV resists will also gain traction due to performance capabilities. Older technologies like G & I line are expected to also show growth in proportion to wafer starts, whereas the leading-edge materials will grow at a rate dependent on number of layers for different device types and technology nodes.

Advanced device processes will impact material usage as follows:

Advanced logic devices will continue to require an increased number of photolithography steps per wafer start, driving for more EUV and increased 193nm (ArF) layers. However, many of the current immersion 193nm (i193nm) process steps are likely to be replaced by EUV, & i193nm related lithography materials will also decline.

At the Gate-All-Around (GAA), also called nanosheet or nanoribbon transistors nodes, backside power rail will be added which will drive even more litho steps.

DRAM has also started to use EUV, replacing some ArFi (i193nm) process steps. New DRAM devices are expected to increase overall litho steps per wafer.

3D NAND will also continue to add more layers and stacks, increasing the overall number of all process steps, including lithography steps, per wafer.

Other significant trends impacting materials include the focus on the strengthening of in-country supply-chains and chip production. This has started to impact legacy photolithography chemical makers. For example, Chinese companies are emerging as diazo photoresist makers, while Korean lithography material makers are also gaining momentum.

[ebr-software]

We at EBR provides the best HR and payroll software in Dubai, when your business is running overload with HR tasks we strongly recommend you to use our HR and payroll software in Dubai, we developed HR and payroll software in Dubai most effective and smartest way. We ensure you the software program brings more productivity in your organization.

Visit us for more information

Call : +971557873346

[ecuadorbikerental]

Francisco, also known by everyone as Pancho has been working with EBR since mid 2018 and, he has built a strong rep as a tour guide. His background as a consultant in travel agencies works on his behalf when it comes to know what our clients want to see and what becomes redundant or too touristy for them. Guided tours with Pancho are filled with knowledge, fun and excitement. He is a bilingual, great photographer and amazing rider which thanks to his endless hours on top of his KLR 650 around the country, he developed “the must go places” and a keen sense of where the fun is. From crossing rivers, to the best food on the road. We encourage you to take a tour with our dear friend and leave Ecuador with the feeling that you really got the most out of it. www.ecuadorbikerental.com Ecuador Bike Rental by Sleipner Custom tailored adventures #ecuadorbikerental #betheregps #syrus3g #ecuador #Quito #allyouneedisecuador #MakeLifeARide #adventure #adventurebike #adventuretravel #motorcycletouring #dualsportadv #madeforadventure #dualsport #advlife #mototravel_lovers #motolife #royalenfield #klr650 https://www.instagram.com/p/CDEJPJYncY-/?igshid=qisvvhqt3d0p

[lakadyn]

SMOAK Technologies RIP

One of the thing that bugs me the most concerning Felicity is that she was supposed to be this genius CEO. We had a touch of that in S4 but by S7 Felicity had given up everything for Oliver even though it was established she was never “that woman”. 

Yes she created Archer but it was only to protect her family not to make the world a better place and in the end her creation was stolen to become an instrument of fascism that could destroy lives. 

EBR did want Felicity to be a CEO more than she wanted her to have a baby, to tell the truth when I met her in Paris during People Convention, she seemed annoyed every time someone mentioned a wedding or a baby as if her character could only be reduced to that. 

As much as I adore Olicity, I could imagine the baby in their future, I didn’t need it on screen what I wanted (and it might be one of the reason EBR left before the end of the show) was character development with Felicity learning how to run a successful business, creating amazing tech, vanquishing rival CEOs. I needed that and I’m sure EBR would have loved that as well. 

And if at least we had had a truly happy ending, but no, even if the last shot (thanks to SA btw, the writers didn’t even think about that, the suckers) gives us hope of a reunion, they turned Felicity into Penelope. You know Penelope in the Ullysses mythology. She stays at home raising children while her husband leads an adventurous life and she gets him after 20 or so years. 

Never, ever would have I thought they would turn Felicity into that. This is unforgivable. She is so much more and EBR and SA sure knew it. The writers who created her by accident, could never cherish the gem she was. Hence my anger and my disappointment. She deserved better, WE deserved better. 

[german-killua]

Catching up on Arrow is freaking amazing. I am right now in Season 4 and..my god people.

Like its downright educational. I cannot begin to understand how someone can throw their characters under a bus like this.

Every time they tell the audience how great felicity is, I keep thinking about that one time when she became a Doctor overnight, build a holographic table, did an AUTOPSY ON SARA (Because that's not fucked up at all), developed a programme to do a holographic projection of it, claimed that Sara could not have been killed by a normal Bow and Arrow...

Only to be swiftly proven absolutely wrong by the flashback revealing Thea with a Normal Bow and Arrow. I mean the other characters are getting the shaft too, but I came around from hating her for being such a bad character do downright feeling pity for her now. EBR is a way better actress than this and what they give her is atrocious. The entire scene where Felicity, now UNABLE TO WALK has to console her husband and never gets reassuring words from him, the motherfuck just talking behind her back how “Great and strong” she is?

Like...that's vile. And when they finally give her something to work with, they just abandon it. At least 3 times in the show as far as I know. I am seriously not looking forward to more Character assassination.

Oh and Felicity claiming: “My new codename should be Hotwheels” only to then claim she is not ready for the team AFTER claiming in the LAST EPISODE she wants back in...

...I...Seriously somebody should get slapped. 

[lewisonia]

Insights on the Liquid Biopsy Market to 2029

Research Nester published a report titled “Liquid Biopsy Market: Global Demand Analysis & Opportunity Outlook 2029″ which delivers detailed overview of the global liquid biopsy market in terms of market segmentation by type of biomarker, application, sample collection type, product type, technology, end-user, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global liquid biopsy market is segmented by end-user into academic & research centers, hospitals & laboratories, and others, out of which, the hospitals & laboratories segment is projected to hold the largest market share by the end of 2021 owing to the increasing number of tests being done in in-house hospital laboratories and external laboratories.

Get a PDF Sample for more detailed market insights: https://www.researchnester.com/sample-request-69

Increasing Prevalence of Cancer and the Need for Early Diagnosis

The World Health Organization (WHO), in one of its statistics, stated that globally, the second leading cause of death is cancer. Additionally, deaths caused due to cancer in the year 2018, registered to around 9.6 million cases.

The statistics portray the growing prevalence of cancer globally and therefore the increasing need amongst individuals for its early detection. Increasing preferences of medical practitioners for minimally invasive and non-invasive methods of sample collection for the detection of cancer is leading to the increase in adoption of liquid biopsy procedures. This procedure further allows the healthcare practitioners to gain more information on the cancer type and also allows real-time analysis. Moreover, increasing advancements in clinical research is further anticipated to drive the growth of the market during the forecast period.

The global liquid biopsy market is anticipated to grow with a significant CAGR during the forecast period, i.e., 2021-2029, owing to the numerous advantages of liquid biopsy over the conventional tumor biopsy, such as low risks, enhanced monitoring for drug response and resistance, and others, along with the rising awareness about minimally invasive procedures.

Regionally, the global liquid biopsy market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa regions, out of which, the market in North America is anticipated to hold the largest market share by the end of 2021, backed by the growing healthcare infrastructure in the region, and the increasing advancements in research for the development of different analytical techniques for cancer.

However, the low specificity and sensitivity of liquid biopsy for the detection of cancer biomarkers is expected to operate as key restraint to the growth of the global liquid biopsy market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global liquid biopsy market which includes company profiling of OmeCare Inc. (Pathway Genomics), Biocept, Inc. (NASDAQ: BIOC), Exosome Diagnostics, Inc., QIAGEN GmbH (NYSE: QGEN), Roche Diagnostics (OTCMKTS: RHHBY), Bio-Rad Laboratories, Inc. (NYSE: BIO), NeoGenomics Laboratories, Inc. (NASDAQ: NEO), Biocartis NV (EBR: BCART), Guardant Health, Inc. (NASDAQ: GH), and Trovagene, Inc. (Cardiff Oncology) (NASDAQ: CRDF).

Access Full Report, here: https://www.researchnester.com/sample-request-69

The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global liquid biopsy market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

About Research Nester:

Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.

Contact Us:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

[industry-reports-data]

High Performance Polymers Market 2022 Trends, Growth Opportunities, Industry Revenue and Business Analysis by Forecast – 2027

High Performance Polymers Market” research report covers inclusive data on prevalent trends, drivers, growth opportunities, and restraints that can variation the market changing aspects of the global industry. This report provides an in-depth analysis of the market segmentation that contains products, applications, and geographical analysis. Global High Performance Polymers market report delivers a close watch on leading participants with strategic analysis, micro and macro market trend and scenarios, pricing analysis, and a complete overview of the industry conditions during the forecast period.

Report Coverage:

The research report of the defending coatings industry offers a inclusive analysis of existing companies that can affect the market outlook throughout the forthcoming years. In addition to that, it affords an accurate assessment by highlighting data on multiple aspects that may contain growth drivers, opportunities, trends, and hindrances. It also represents the overall: High Performance Polymers market size from a global perception by analysing historical data and qualitative insights.

High Performance Polymers Market is envisaged to record an expansion at the CAGR of 8% over the forecast period, 2022 – 2027.

Strong expertise with attention to detail makes our market research reports stand apart, Request a Report Sample PDF here:

Major Players Operating in the: High Performance Polymers Market:

Celanese Corporation, Daikin Industries, Ltd., Daikin Industries, Ltd. (ETR: EVK), Solvay SA (EBR: SOLB), Sumitomo Chemical, Arkema SA (EPA: AKE), DIC Asset AG, DowDuPont, Kuraray, RTP, SABIC, Unitika, BASF SE and other

High Performance Polymers Market Analysis:

The High Performance Polymers market research report provides an in-depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. The segmentation chapters enable readers to understand aspects of the market such as its products, market size, manufacturer details, share, available technology, and applications. The research report also provides detailed information on new trends that may define the development of these segments in the coming years.

On the basis of types, the: High Performance Polymers market is primarily split into

Fluoro Polymer

Liquid Crystal Polymers

Polyamides

Polyimides

Polyketone

On the basis of applications, the: High Performance Polymers market covers:

Construction

Printing Inks

Elastomers

Textiles

Water Treatment

Packaging

Others

For More Information or Query or Customization Before Buying, Visit @

Ehttps://www.industrydataanalytics.com/reports/high-performance-polymers-market?mode=Nikita

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in High Performance Polymers market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in High Performance Polymers market.

Considering the Geographical Landscape of High Performance Polymers market:

High Performance Polymers Market report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities.

➤ North America (United States, Canada, and Mexico)

➤ Europe (UK, Germany, France, Russia, and Italy)

➤ Asia-Pacific (China, Korea, Japan, India, and Southeast Asia)

➤ South America (Brazil, Colombia, Argentina, etc.)

➤ The Middle East and Africa (Saudi Arabia, UAE, Nigeria, Egypt, and South Africa)

Research Methodology:

This report offers actionable growth insights and an extensive report comprising secondary research, primary interviews with industry stakeholders, competitors, validation, and triangulation with the Worldwide Market Reports regional database. Experts have detailed primary records with the market players across the value chain in all regions and industry experts to obtain qualitative and quantitative insights.

Key Benefits for: High Performance Polymers Market Reports:

✦ What is the global sales value, production value, consumption value, import, and export of industry?

✦ Who are the global key manufacturers of High Performance Polymers industry? What is their operating situation?

✦ What are High Performance Polymers market opportunities and threats faced by the vendors in the global High Performance Polymers Industry?

✦ Which application/end-user or product type may seek incremental growth prospects?

✦ What focused approach and constraints are holding the market?

✦ What are the different sales, marketing, and distribution channels in the global industry?

About Us:

IndustryDataAnalytics is your single point market research source for all industries including pharmaceutical, chemicals and materials, energy resources, automobile, IT, technology and media, food and beverages, and consumer goods, among others.

We will get in touch with you within 24hrs and help you find the research reports and Additional Customization you need

Head of Sales: Mr. Hon Irfan Tamboli

 +1 (704) 266-3234 | contact@industrydataanalytics.com High Performance Polymers Market Opportunity, High Performance Polymers Market Size, High Performance Polymers Market Growth, High Performance Polymers Market Research,

[databrigemarketresearchreports]

Leadless Cardiac Pacemaker Market Overview and Growth Prospects Predicted by 2028

As Leadless Cardiac Pacemaker market report has precise and accurate analysis of market trends, future developments, market segments and competitive analysis which suits the needs of all sizes of businesses. This market research report is one of the best and wide-ranging market reports which provide market insights by considering number of factors. The report highlights CAGR value fluctuation, historic data, current market trends, market environment, technological innovation, upcoming technologies and the technical progress in the related industry. Leadless cardiac pacemaker market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to reach at an estimated value of USD 269.18 million by 2028 and grow at a CAGR of 17.19% in the above-mentioned forecast period. Rise in the number of cardiac procedures with leadless pacemaker drives the leadless cardiac pacemaker market.

Ask for Sample Report at https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-leadless-cardiac-pacemaker-market  

Some of the market players studied in this report are:

Abbott, Medtronic and EBR Systems, Inc among other domestic and global players. 

The ozone therapy in the dermatology market is segmented on the basis of type and application.

·         On the basis of product, leadless cardiac pacemaker market is segmented into micra transcatheter pacing system, nanostim leadless pacemaker and others.

·         The leadless cardiac pacemaker market is also segmented on the basis of end-user into hospitals, ambulatory surgical centers, academic & research institutes and others.

Request for Customization https://www.databridgemarketresearch.com/customization/global-leadless-cardiac-pacemaker-market The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Leadless Cardiac Pacemaker market.

Product Development/Innovation: Detailed insights on the upcoming technologies, RD activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Global Leadless Cardiac Pacemaker market.

Why should buy this report?

1.          Provides in depth research analysis of the overall Leadless Cardiac Pacemaker market. which can help save time for start-up businesses related to the Leadless Cardiac Pacemaker Market.

2.          The Leadless Cardiac Pacemaker markets latest news, forecast analysis as well as the key competitors of the market are easily available with all the necessary information.

3.          The Leadless Cardiac Pacemaker report comprises of graphs, pie charts and other representations that can help the reader understand the information at a glance.

4.          Through the Leadless Cardiac Pacemaker report the manufacturers can understand the consumer behaviour, business segments as well as sell products-based information provided.

TOC of the report https://www.databridgemarketresearch.com/toc/?dbmr=global-leadless-cardiac-pacemaker-market

Thank you for reading our report. For further inquiry, please get in touch with us. Our team will ensure the report is customized to meet your requirements.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818 Email: Sopan.gedam@databridgemarketresearch.com 

[processxe]

Automation and paper elimination in pharmaceuticals with electronic batch records

Batch Records Software

Process XE batch records software workflows are 100% configurable. No coding required.

What is a Batch Record?

A batch record is a record of the history of a manufactured product. It comprises processing instructions to assure its safety, quality, and GMP compliance.

As a result, pharmaceutical businesses choose to use Electronic Batch Record (EBR) in order to streamline production and reduce the potential of mistakes seeping in. This article demonstrates how the system facilitates document generation in the pharmaceutical industry, from bulk to packaging processes.

What is Electronic Batch Records all about?

The pharmaceutical business that wishes to apply innovative solutions in manufacturing is concerned with more than just the digitization of forms. The EBR system is also designed to reduce the time necessary to fill out form fields and eventually lead to automatic form completion by gathering data directly from machines. Data collection directly from equipment such as scales, pH meters, and conductivity meters is frequently required as well. Furthermore, the organization wishes to avoid mistakes and track deviations from the standard that occur during the manufacturing process.

The deployment of the Process XE system results in more than just efficient documentation digitalization. Operators are directed through the manufacturing process, which includes changeovers, quality, logistics, and maintenance. Process XE is being compiled using GMP by the system.

This greatly simplified the process of creating or changing forms. However, this still necessitates the use of authorized individuals; only those with the necessary access may make modifications to the forms. All of this is done to avoid mistakes or inappropriate processing.

What does the Process XE solution offer for Pharma?

Process XE provides an all-inclusive solution that includes machine data collecting, hardware, ERP integration, and infrastructure. This method also allows you to create MBR templates. Clients can develop Master Batch Record (MBR) templates by arranging all actions in the system in the correct sequence and assigning responsibility for each role. Each activity may be customized with several reporting data kinds such as numbers, text, and data retrieved from automation, among others. These results can subsequently be checked against the system's quality limitations.

Fields in forms that have been implemented include whether or not an action has been done. A production value column and information about when a given activity was begun or stopped, as well as a computation of the time spent on it, are also among the modifications. There is also an electronic signature placed on the form and comments or remarks made by the responsible person among the implementations.

What does a paperless procedure in the pharmaceutical sector look like?

The paperless process includes digitally directing the operator through particular portions of production, beginning with the activity display - the production to-do list. It also contains changeover information and documentation for each production phase (picture, text, and video). Using Forms, all paper documentation from production are digitized.

All sheets, tables, and reports are immediately fielded with data from current shifts thanks to Process XE. The system monitors and alerts the operator when the task must be finished. Any modifications or deviations are tracked using an audit trail.

To be released, each batch must go through the Process XE system's approval procedure. This relates to the workflow aspect. The persons who notify certain positions in the organization must sign each step with an electronic signature. If the current step in the workflow is allocated to a certain role, notifications are issued. People with the necessary rights may observe where the batch release process has halted and track KPIs for the time it takes to finish each step.

Digital Records Management with Electronic Batch Records

EBR works because of all of the criteria mentioned above. This provides digital documentation management throughout the manufacturing process. The system ensures that the essential data is entered into the stages. EBR generation yields a PDF file with finished reports and signatures.

What are the benefits of this for the pharmaceutical business?

To begin, the system reduces batch release time by 35% owing to workflow and automatic data collection. Material validation, frequent quality inspections, and step-by-step digital teaching also result in 15% reduced mistakes and waste. It also delivers a 7% boost to OTIF.

The use of EBR also facilitates speedier communication between business divisions, contributes to the removal of paper from the manufacturing process, and allows for round-the-clock monitoring of current batch release statuses.

Process XE provides the solutions your pharmaceutical company need to improve workflow efficiency and environmental friendliness. Please contact a member of the team for more personalized help.

Process XE is web based, flexible and user-friendly software solutions for Business process automation.

This Digital, Smart Manufacturing process automation is principally developed for Pharmaceutical, Life science and Healthcare industries to simplify their manufacturing execution system of various processes such as data capture, batch information exchange, batch production management, data security maintenance, data integrity and report production, ensuring compliance to cGMP requirements.

For more details on MES, Contact our sales team. <Book A Demo>

[stevecarell600]

Medical Drone Market Key Drivers, Industry Size, Regional Investments and Top Segments Data Forecast

A medical drone is an unmanned aerial vehicle (UAV) that is specifically designed to transport medical supplies, equipment, and even personnel to remote or hard-to-reach areas. Medical drones have the potential to revolutionize healthcare delivery by overcoming traditional transportation barriers such as traffic congestion, rough terrain, or lack of infrastructure.

Information Source:

Medical drones can be equipped with a variety of medical payloads, including defibrillators, medications, blood products, and diagnostic equipment. They can also be used for emergency response, such as delivering medical supplies to disaster zones or transporting organs for transplant.

One of the key advantages of medical drones is their speed and agility. They can reach remote locations much faster than traditional methods of transportation, which can mean the difference between life and death in emergency situations. They also have the potential to reduce healthcare costs by increasing efficiency and reducing the need for traditional transportation methods.

The global medical drone market size is expected to gain momentum by reaching USD 1,410.9 million by 2028 from USD 254.7 million in 2021 while exhibiting an impressive CAGR of 27.70% between 2021 to 2028. In its report titled, “Medical Drone Market, 2021-2028,” Fortune Business Insights™ mentions that the market stood at USD 194.7 million in 2020.

The technological advancement and ongoing competition between major players to deliver the best product are expected to drive the market in upcoming years. Thus, major players such as Volocopter, Zipline, Volansi, Flirtey, Matternet are focused on developing quality drones to ensure their global market position and high demand for medical drones amid the ongoing COVID-19 pandemic

COVID-19 Impact

Amid the COVID-19 pandemic, demand for drones increased. Many deliveries for medical purposes and laboratory samples were done using drone technology. According to a report by various resources, around eighteen countries worldwide were dependent on unmanned technology for logistical purposes. For instance, countries in Sub-Saharan Africa, such as Ghana, Rwanda, and Malawi, are some of the countries which were dependent on drone systems for the delivery of medical supplies, pathological and blood samples, and commodities since 2016 and in pandemic times, they are using it in remote places.

Therefore, advantages that this technology facilitates in the COVID-19 context are on-demand just-in-time delivery, minimal physical contact, last-mile delivery to remote locations with an extended logistical network, and low viral or pathological transmission risk. Thus various such applications in this current situation are expected to fuel the market growth.

What does the Report Provide?

The market report for medical drone provides a detailed analysis of several factors such as the key drivers and restraints that will impact growth. Additionally, the report provides insights into the regional analysis that covers different regions, contributing to the growth of the market. It includes the competitive landscape that involves the leading companies and the adoption of strategies to introduce new products, announce partnerships, and collaborate to contribute to the growth of this market.

 List of Key Players Profiled in Medical Drone Industry Report

Zipline Inc. (San Francisco, United States)

Volocopter GmbH (Bruchsal, Germany)

Volansi Inc. (San Francisco,United States)

Matternet Inc. (Mountain View, United States)

Manna Drone Delivery Inc. (Dublin, Ireland)

Flytrex Aviation Ltd. (Tel Aviv, Israel)

Flirtey Holdings Inc. (Reno, United States)

Vayu Inc. (Ypsilanti, United States)

Skyports Ltd. (Billericay, United Kingdom)

Ebre Drone LLC (Tarragona, Spain)

Swoop Aero Pty. Ltd. (Docklands, Australia)

Skyfarer Ltd. (Coventry, United Kingdom)

Driving Factor

High Demand for Drones in Healthcare Applications to Propel Market Growth

The increasing demand for monitoring and surveillance of public areas and the advent of new logistical alternatives than the conventional supply chain modes is propelling governments worldwide to invest in medical drone technology. Moreover, in this pandemic situation, human contact has been suspected to be a vehicle of viral transmission. Thus drone technology is a clear winner in this situation. Thus, there has emerged an urgent need for contactless and efficient technology. For instance, in October 2019, the UPS Flight Forward Inc. has received U.S. government approval with the Federal Aviation Administration's and standard certification to exercise drone airline operations. In response, the company launched its first drone delivery flight at WakeMed Hospital in Raleigh, NC, by using a quadcopter Matternet M2. These factors are driving the medical drone market growth.

Market Segmentation:

By type, the market is segmented into fixed-wing, rotary-wing, and hybrid. Technology is divided into fully autonomous, semi-autonomous, and remotely operated. By the package size, it is trifurcated into <2 KG, 2-5 KG, and 5 KG <. On the basis of its service, it is divided into hospital-based, independent, and government. Based on its logistical application, it is divided into emergency blood logistics, medicinal drugs logistics, medical equipment logistics, surgical equipment logistics, vaccine logistics, emergency organ logistics, and emergency ambulatory support. By End-user, it is segmented into emergency medical services, blood banks, hospitals, and others.

Finally, based on region, the market is categorized into North America, Europe, Asia Pacific, and the Middle East & Africa.

Regional Insights

North America to Dominate Backed by Increasing Number of Registered Drones

North America is expected to remain at the forefront and hold the highest position in this market during the forecast period owing to a large number of drones, i.e., around 872,694 drones that are registered for use under Federal Aviation Administration (FAA,) in 2021. The region’s market stood at USD 79.88 million in 2020.

Asia Pacific is expected to showcase significant medical drone market share during the forecast period owing to the high adoption rate and investment by OEMs and governments. Furthermore, the presence of the OEMs in the region, such as DJI, and global players such as Zipline.

The Middle East is anticipated to be the fastest-growing region during the forecast period. The regional market growth results from high investment by regional governments such as Ghana, Rwanda, Nigeria, and others for various medical drone applications.

Competitive Landscape

Key Players to Focus on Partnerships to Strengthen Their Market Positions

This market is consolidated by major companies striving to maintain their position by focusing on new launches, partnerships, and agreements. For instance, in February 2021, the Government of Kaduna State, in Nigeria, signed a medical delivery agreement with Zipline for airdropped COVID-19 Vaccine shipment as it would have reduced the dependency of the state to invest in the cold chain storage. Furthermore, this agreement is expected to pave the way for enhanced services such as on-demand blood products, medications, and other vaccines.